Search results
Results From The WOW.Com Content Network
The Liusons, a traditional Chinese family has been involved in the pharmaceutical industry since 1959 through Pacific Pharma, an importer and wholesaler of drugs. [3] In 1983, Pacific Pharma shifted to investing on generic drugs. [3] The company initially largely sold generic drugs wholesale to government hospitals. [4]
The PSE Composite Index, or the PSEi (previously PHISIX), is a stock market index of the Philippine Stock Exchange (PSE) always consisting of 30 of the largest companies traded on the stock exchange. [1] This is in contrast to the PSE All Shares Index which is an index of all stocks traded on the PSE.
AstraZeneca claimed the deal undervalued the company. [15] 4 2014 Pfizer: Astra Zeneca: 99 127 AstraZeneca claimed the deal undervalued the company. [16] 5 1999 Pfizer: Warner–Lambert: 82.4 151 Pfizer made a hostile bid, just after the announcement of a $72 billion deal with Wyeth, the eventual purchase price would be in excess of $90 billion ...
The Federal Trade Commission had its first win earlier this week in its crusade to block drug company deals: Sanofi on Monday ended its up-to-$735 million licensing deal with Maze Therapeutics.
Industry. PhRMA: "The administration is using the IRA’s price-setting scheme to drive political headlines," the pharma industry trade group said in a statement, "but patients will be ...
The Ground Level of the New Headquarters of the Philippine Stock Exchange in Bonifacio Global City. The Old Headquarters and Trading floor of the PSEi and the Makati Stock Exchange in Ayala Tower One in the Makati Central Business District. Philippine Stock Exchange Center is located on Exchange Road, Ortigas Center, Pasig. [7]
Humulin saw the biggest price hike, rising 1,070.1% from $67 in 2012 to $1,512 in 2022. Adriana Belmonte is a reporter and editor covering politics and health care policy for Yahoo Finance.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.